Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07227922
PHASE1
Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Sponsor: Sparrow Pharmaceuticals
View on ClinicalTrials.gov
Summary
This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.
Key Details
Gender
All
Age Range
18 Years - 83 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2025-11-30
Completion Date
2026-07-01
Last Updated
2025-12-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
12mg clofutriben
Each participant will receive a single oral dose of clofutriben
Locations (1)
Orlando Clinical Research Center
Orlando, Florida, United States